PT - JOURNAL ARTICLE AU - Juan G. Diaz O. AU - Lukas Maier AU - Orsolya Csiszár TI - Bayesian Logical Neural Networks for Human-Centered Applications in Medicine AID - 10.1101/2021.11.15.21266351 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.15.21266351 4099 - http://medrxiv.org/content/early/2021/11/16/2021.11.15.21266351.short 4100 - http://medrxiv.org/content/early/2021/11/16/2021.11.15.21266351.full AB - Medicine is characterized by its inherent ambiguity, i.e., the difficulty to identify and obtain exact outcomes from available data. Regarding this problem, electronic Health Records (EHRs) aim to avoid imprecisions in the data recording, for instance by its recording in an automatic way or by the integration of data that is both readable by humans and machines. However, the inherent biology and physiological processes introduce a constant epistemic uncertainty, which has a deep implication in the way the condition of the patients is estimated. For instance, for some patients, it is not possible to speak about an exact diagnosis, but about the “suspicion” of a disease, which reveals that the medical practice is often ambiguous. In this work, we report a novel modeling methodology combining explainable models, defined on Logic Neural Networks (LONNs), and Bayesian Networks (BN) that deliver ambiguous outcomes, for instance, medical procedures (Therapy Keys (TK)), depending on the uncertainty of observed data. If epistemic uncertainty is generated from the underlying physiology, the model delivers exact or ambiguous results depending on the individual parameters of each patient. Thus, our model does not aim to assist the customer by providing exact results but is a user-centered solution that informs the customer when a given recommendation, in this case, a therapy, is uncertain and must be carefully evaluated by the customer, implying that the final customer must be a professional who will not fully rely on automatic recommendations. This novel methodology has been tested on a database for patients with heart insufficiency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project no. 2019-2.1.11-TET-2020-00217 has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the 2019-2.1.11-TET-2020-00217 funding scheme.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://archive.ics.uci.edu/ml/datasets/Heart+failure+clinical+recordsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://archive.ics.uci.edu/ml/datasets/Heart+failure+clinical+records